"Dancing with the Stars" host and cervical cancer survivor Erin Andrews fights to save lives

Hologic is the market-leading supplier in the United States of Pap tests and HPV (human papillomavirus) tests, frequently used together on the same sample to screen for cervical pre-cancer and cancer (an approach known as Pap+HPV Together or co-testing). According to guidelines from the American College of Obstetricians and Gynecologists, women under the age of 30 should get regular Pap testing, with co-testing being the preferred approach for women 30 to 65.⁴

"Surviving cervical cancer made me recognize how fortunate I am to be in a position to advocate for lifesaving tests," said Andrews. "I'm asking every woman to join me in making an appointment for their annual exam – and to tell the women they love to do it, too."

To learn more, please visit ChangeThisSTAT.com.

About cervical cancer
Over the last 40 years, the number of cervical cancer cases has been cut in half, thanks largely to regular testing, which can identify abnormalities before they become cervical cancer.⁵

Though about eight out of 10 women will contract HPV at some point in their lives, most of the time the virus goes away. In some cases, however, it can remain and promote development of cervical cancer. For women between 30 and 65, the preferred screening approach is to test with Pap+HPV Together, which detects 95 percent of cervical cancer cases.⁶ Screening with both tests also prevents more cases of pre-cancer than either test used alone.⁶ In fact, the largest retrospective study of cervical cancer testing strategies found that one out of five cases of cervical cancer was missed when the HPV test was used alone.⁶

About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Forward-Looking Statements
This press release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic's diagnostic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient. The actual effect of the use of the products can only be determined on a case-by-case basis depending on the particular circumstances and patient in question. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.

Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc. in the United States and/or other countries.

Investor Contact:
Michael Watts
+1 858.410.8588
michael.watts@hologic.com

Media Contact:
Jane Mazur
+1 508.263.8764 (direct)
+1 585.355.5978 (mobile)
jane.mazur@hologic.com

References:

1. American Cancer Society. Cancer facts and figures 2017. 2017.
2. Centers for Disease Control and Prevention. Cervical cancer is preventable. Centers for Disease Control and Prevention Website. https://www.cdc.gov/vitalsigns/cervical-cancer/index.html. Updated November 2014. Accessed February 13, 2018.
3. Benard VB et al. Vital signs: cervical cancer incidence, mortality, and screening – United States, 2007-2012. Morbidity and Mortality Weekly Report. 2014;63:1.
4. The American College of Obstetricians and Gynecologists. Practice bulletin No. 157: Cervical cancer screening and prevention. Obstetrics and Gynecology. 2016;127(1):185-7.
5. American Cancer Society. Cancer facts and figures 2017. 2017:27.
6. Blatt et al. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathology. 2015;123(5):282-288 [Study included ThinPrep®, SurePath®, Hybrid Capture® 2 assay].

View original content:http://www.prnewswire.com/news-releases/dancing-with-the-stars-host-and-cervical-cancer-survivor-erin-andrews-fights-to-save-lives-300610634.html

SOURCE Hologic, Inc.